CMMB insider filings
Chemomab Therapeutics Ltd. — 9 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-09-01. Screen CMMB transaction legs live →
Insider transaction summary — last 90 days
2026-07-10 to 2026-10-08, from the filings listed below: 1 insider filing (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 1 filing by 1 insider — 2,304 shares, $6,516 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: sale of 1,304 shares @ $2.85 ($3,716) by Cohen Neil Harris, filed 2026-09-01.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Cohen Neil Harris — Director | 1 | — | 2 legs · 2,304 sh · $6,516 | 7 |
Recent insider filings — Chemomab Therapeutics Ltd.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-01 | 4 | Cohen Neil Harris — Director | Sale (S): 1,304 @ $2.85 · Sale (S): 1,000 @ $2.80 · Grant/award (A): 172 (derivative) @ $0 · Grant/award (A): 2,971 (derivative) @ $0 · Grant/award (A): 1,705 (derivative) @ $0 · Grant/award (A): 1,714 (derivative) @ $0 · +3 more | EDGAR |
| 2026-06-01 | 4 | Mor George Adi — Chief Executive Officer, Director | Purchase (P): 4,878 @ $2.05 · Purchase (P): 4,926 @ $2.08 · Other (J): 31,712 · Other (J): 18,750 | EDGAR |
| 2023-07-05 | 4 | Darvish Nissim — Director | Grant/award (A): 20,572 (derivative) @ $0 · Grant/award (A): 6,857 (derivative) @ $0 · Grant/award (A): 6,820 (derivative) @ $0 · Grant/award (A): 11,884 (derivative) @ $0 · Grant/award (A): 10,123 (derivative) @ $0 | EDGAR |
| 2023-06-20 | 4 | Quigley Jill M. — Director | Grant/award (A): 6,857 (derivative) @ $0 · Grant/award (A): 13,640 (derivative) @ $0 | EDGAR |
| 2023-06-16 | 4 | Fatal Sigal — Chief Financial Officer | Grant/award (A): 102,860 (derivative) @ $0 · Grant/award (A): 29,400 (derivative) @ $0 · Grant/award (A): 35,600 (derivative) @ $0 | EDGAR |
| 2023-03-23 | 4 | Moses Alan Charles — Director | Grant/award (A): 6,857 (derivative) @ $0 · Grant/award (A): 6,820 (derivative) @ $0 · Grant/award (A): 11,884 (derivative) @ $0 | EDGAR |
| 2023-03-23 | 4 | Nicaise Claude — Director | Grant/award (A): 6,857 (derivative) @ $0 · Grant/award (A): 6,820 (derivative) @ $0 · Grant/award (A): 11,884 (derivative) @ $0 | EDGAR |
| 2023-03-23 | 4 | Cohen Neil Harris — Director | Grant/award (A): 6,875 (derivative) @ $0 · Grant/award (A): 6,820 (derivative) @ $0 · Grant/award (A): 11,884 (derivative) @ $0 · Grant/award (A): 688 (derivative) @ $0 | EDGAR |
| 2023-03-23 | 4 | Darvish Nissim — Director | Grant/award (A): 6,857 (derivative) @ $0 · Grant/award (A): 6,820 (derivative) @ $0 · Grant/award (A): 11,884 (derivative) @ $0 · Grant/award (A): 10,123 (derivative) @ $0 | EDGAR |
Recent 8-K events — Chemomab Therapeutics Ltd.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2023-06-16 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2023-06-05 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-05-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-02-21 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-02-21 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CMMB returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →